TABLE 1.

Recipient characteristics

	Historic cohort(n = 44)	Modern cohort(n = 68)	P
Age (y)	55 (49.0–59.2)	57 (50.8–62.2)	0.18
Gender (male)	26 (59.1%)	45 (66.2%)	0.55
Race			0.49
Caucasian	32 (72.7%)	48 (70.6%)
African American	10 (22.7%)	16 (23.5%)
Hispanic	0 (0.0%)	3 (4.4%)
Asian	2 (4.5%)	1 (1.5%)
Physiological MELD-Na  at transplantation	22.5 (14.2–29.8)	20 (13.0–28.0)	0.48
Hepatocellular carcinoma	11 (25.0%)	21 (30.9%)	0.53
Hepatitis C virus infection	21 (47.7%)	25 (36.8%)	0.33
Cause of liver disease			0.51
Viral hepatitis	21 (47.7%)	27 (39.7%)
Alcohol	12 (27.3%)	14 (20.6%)
NASH	4 (9.1%)	14 (20.6%)
Cholestatic	2 (4.5%)	3 (4.4%)
Other	5 (11.4%)	10 (14.7%)

Data are presented as median (interquartile range) and number (percentage).

MELD-Na, model of end-stage liver disease-sodium; NASH, nonalcoholic steatohepatitis.